No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

Additional Metadata
Keywords	Acute myeloblastic leukaemia, Bone marrow transplantation, Cytarabine
Persistent URL	doi.org/10.1046/j.1365-2141.2000.02178.x, hdl.handle.net/1765/65905
Journal	British Journal of Haematology
Organisation	Department of Hematology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Cahn, J.-Y., Labopin, M., Sierra, J., Blaise, D., Reiffers, J., Ferrant, A., Bergmann, L., Visani, G., Cornelissen, J., de Witte, T., Bosi, A., Frassoni, F.& Gorin, N.-C. (2000). No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. British Journal of Haematology, 110(2), 308–314.https://doi.org/10.1046/j.1365-2141.2000.02178.x

Publication